Defining and predicting deep remission in patients with perianal fistulizing Crohn’s disease on anti-tumor necrosis factor therapy

Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease

(2017) Lucie Thomassin et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases

(2016) Bella Ungar et al.   Clinical Gastroenterology and Hepatology

Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis

(2016) Konstantinos Papamichael et al.   Clinical Gastroenterology and Hepatology

Association of Induction Infliximab Levels With Clinical Response in Perianal Crohn’s Disease

(2016) Yana Davidov et al.   Journal of Crohns & Colitis

Results of the Fifth Scientific Workshop of the ECCO [II]: Clinical Aspects of Perianal Fistulising Crohn’s Disease—the Unmet Needs: Table 1.

(2016) Krisztina B. Gecse et al.   Journal of Crohns & Colitis

Rapid Test for Infliximab Drug Concentration Allows Immediate Dose Adaptation

(2016) Thomas Van Stappen et al.   Clinical and Translational Gastroenterology

Effectiveness of Adalimumab in Perianal Fistulas in Crohn’s Disease Patients Naive to Anti-TNF Therapy

(2015) Carlos Castaño-Milla et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Combination of C-reactive Protein, Infliximab Trough Levels, and Stable but Not Transient Antibodies to Infliximab Are Associated With Loss of Response to Infliximab in Inflammatory Bowel Disease

(2015) X. Roblin et al.   Journal of Crohns & Colitis

Long-Term Outcome of Enterocutaneous Fistula in Patients With Crohn's Disease Treated With Anti-TNF Therapy: A Cohort Study from the GETAID

(2014) Aurelien Amiot et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease

(2014) Krisztina B Gecse et al.   GUT

Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn’s disease – clinical observations from a tertiary Eastern European center

(2014) Renáta Bor et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Therapeutic Drug Monitoring of Infliximab and Mucosal Healing in Inflammatory Bowel Disease

(2013) Stephane Paul et al.   INFLAMMATORY BOWEL DISEASES

Long-term MRI-guided combined anti-TNF-α and thiopurine therapy for crohnʼs perianal fistulas

(2012) Phil Tozer et al.   INFLAMMATORY BOWEL DISEASES

Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience

(2011) José Ignacio Fortea-Ormaechea et al.   Gastroenterologia y Hepatologia

Randomised clinical trial: certolizumab pegol for fistulas in Crohn’s disease - subgroup results from a placebo-controlled study

(2010) S. Schreiber et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Long-Term Monitoring of Infliximab Therapy for Perianal Fistulizing Crohn's Disease by Using Magnetic Resonance Imaging

(2010) Konstantinos Karmiris et al.   Clinical Gastroenterology and Hepatology

Nonfistulizing perianal Crohnʼs disease

(2010) Guillaume Bouguen et al.   INFLAMMATORY BOWEL DISEASES

Fistulizing perianal Crohnʼs disease

(2010) C. Savoye-Collet et al.   INFLAMMATORY BOWEL DISEASES

Prospective Evaluation of Anti-Tumor Necrosis Factor Therapy Guided by Magnetic Resonance Imaging for Crohn's Perineal Fistulas

(2009) Siew C Ng et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Adalimumab for the treatment of fistulas in patients with Crohn's disease

(2009) J-F Colombel et al.   GUT

Predicting Factors of Fistula Healing and Clinical Remission After Infliximab-Based Combined Therapy for Perianal Fistulizing Crohn’s Disease

(2008) David Tougeron et al.   DIGESTIVE DISEASES AND SCIENCES